Printer Friendly

RainEarth applies for patent for second generation blood dialysis equipment.

RainEarth, Inc. (Beijing, China), announced that its contractual partner in China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"), has submitted a patent application for its second generation of blood dialysis.

This second generation blood dialysis has several new features and advantages. These include: a lower broken membrane rate, a higher gap rate, enhanced biological compatibility for the hollow fiber membrane, and an increased dialysis rate.

China RainEarth has applied for patents in a variety of areas with the State Intellectual Property Office of P.R.C (SIPO) including:

--Scale manufacture method for hollow fiber membranes

--Quick drying equipment for hollow fiber membranes

--Device for adjusting dry spinning range in hollow fiber membrane that includes dry-wet spinning and control condensation bath process concentration control

--Synthetic hollow fiber membrane continuous spinning device

--Hollow fiber membrane porous spinneret component

--Hollow fiber tube-in-orifice spinneret

In May 2009, the China State Council passed new regulations not only to speed up the development of the biological industry in China but also to enhance bio-tech patent protection. Products with intellectual rights, once reviewed and approved, will be included in the national Medical Plan catalog.

"We continuously improve our products and protect our intellectual property by applying for patents. These advantages give China RainEarth a strong position in hollow fiber membrane manufacturing and related fields, solidifies our leadership position and ensures that we stay ahead of our competition", said Mr. Zhu, CEO of the company.

RainEarth Inc. (formerly Gold Rock Resources, Inc.) was incorporated in the State of Nevada on March 14, 2006. The company is a developing stage company that initially engages in the search for mineral deposits or reserves.

On March 25, 2009, the company and China RainEarth, a company organized and existing under the laws of the People's Republic of China, entered into a Business Cooperation Agreement (the "Agreement") for a term of twenty years. The purpose of the Agreement is to jointly conduct Hollow Fiber Mambrane Materials' application and manufacturing business in China (the "Business"). The first product that utilizes this technology is blood dialyzer.

The company will provide Advice and assistance relating to development of marketing and consultancy services, particularly as related to the Business. China RainEarth will give 60% of its revenue after deduction of direct operating costs, expenses and taxes to the company in consideration of the company's services.

RainEarth Inc.

+852-3005-7220
COPYRIGHT 2009 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:May 1, 2009
Words:391
Previous Article:Orexigen Therapeutics announces in-licensing of key patents to further strengthen its intellectual property estate for contrave.
Next Article:Raptor Pharmaceuticals to collaborate with Roche on therapeutic delivery across blood-brain barrier.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters